🔴 WuXi Biologics is trading 4.1% down on October 9 as healthcare stocks faced renewed selling pressure

WuXi Biologics is trading at HK$51.90, down 4.07%, amid broader risk-off sentiment and renewed selling pressure on healthcare stocks.

• No clear company-specific announcement explaining the decline was identified.
• Inflation and interest-rate concerns weighed on Hong Kong shares in recent trading.
• Elevated Treasury yields and oil prices added to broader market concerns, supporting a global-macro explanation rather than a company catalyst.